U. von Mandach
University of Zurich
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by U. von Mandach.
Phytomedicine | 2011
R. Wächter; Rudolf Brenneisen; Matthias Hamburger; Mónica Mennet; Martin Schnelle; A.M. Worel; Ana Paula Simões-Wüst; U. von Mandach
AIMS The use of preparations from Bryophyllum pinnatum (Lamarck) Oken (Kalanchoe pinnata (Lamarck) Persoon) in tocolysis is supported by clinical evidence. We studied here the effect of B. pinnatum leaf press juice and its chemical fractions on the response of human myometrial strips. No data are available if the influence on myometrial strips of the juice differs from that of its components in the chemical fractions, in order to increase the pharmacological effect. METHODOLOGY In vitro study to test the effect of repeated addition of B. pinnatum leaf press juice (BPJ) and its chemical components in several dilutions (undiluted, 1-10%) on myometrium strips hang up in a myograph chamber. Chemical analysis is including HPLC, MPLC with Sephadex LH-20 and TLC. RESULTS All test solutions are inhibiting contractility by reducing the amplitude and the area under the curve (AUC) of the contractions. Undiluted BPJ and its undiluted chemical fraction 4 are reducing most effective these two parameters: the amplitude was at 78% of the baseline (95% CI (77-89); p<0.05) at the second addition of the BPJ and at 70% (95% CI (50-90); p<0.05) of the first addition of fraction 4; the AUC was at 82% (95% CI (69-95); p<0.05) of the baseline at the first addition of the press juice and at 51% (95% CI (27-74); p<0.05) at the first addition of fraction 4. The BPJ decreased amplitude and AUC significantly faster and increased frequency significantly faster than the control. Fractions could be tentatively assigned to bufadienolids, flavonoids and cinnamic acids. Fraction 4, accounted for flavonoids, increased the frequency of the contractions most effectively: 557% of the baseline (95% CI (316-797); p<0.05) at the first addition. CONCLUSION Leaf juice of B. pinnatum and its flavonoid fraction are most effective in relaxing myometrial strips by inducing frequency.
Phytomedicine | 2012
V. Schuler; K. Suter; Karin Fürer; Daniel Eberli; M. Horst; Cornelia Betschart; Rudolf Brenneisen; Matthias Hamburger; Mónica Mennet; Martin Schnelle; Ana Paula Simões-Wüst; U. von Mandach
AIMS A broad spectrum of synthetic agents is available for the treatment of overactive bladder. Anti-cholinergic drugs show a poor compliance due to side effects. There is an increasing use of plant extracts in medicine. We have therefore investigated the inhibitory effects of leaf press juice from Bryophyllum pinnatum (Lam.) Oken (Kalanchoe pinnata L.) on bladder strips and compared the effects to that of oxybutynin. METHODS Strips of porcine detrusor were prepared in Krebs solution and contractility was measured in a myograph system chamber aired with O₂/CO₂ at 37 °C. To induce contractions, electrical field stimulation (32 Hz, 40 V) was used for the inhibitory effect measurements, and carbachol (50 μM) for the relaxant effect measurements. Recordings were obtained in the absence and presence of increasing concentrations of Bryophyllum pinnatum leaf press juice (BPJ, 0.1-10%), and oxybutynin (10⁻⁷-10⁻³ M) as a reference substance. RESULTS In inhibition experiments, BPJ as well as oxybutynin inhibited electrically induced contractions of porcine detrusor. BPJ at concentrations of 5% inhibited the contraction compared to a time matched control significantly by 74.6±10.2% (p<0.001). BPJ as well as oxybutynin relaxed carbachol pre-contracted porcine detrusor strips. The maximum relaxant effect of BPJ compared to a time matched control was 18.7±3.7 (p<0.05) at a concentration of 10% BPJ. CONCLUSIONS Our investigations show that BPJ inhibits contractions induced by electrical field stimulation and relaxes carbachol-induced contractions. However, the effect was lower than that of the reference substance oxybutynin. It is important to continue in vitro experiments as well as clinical studies with BPJ that might offer a new treatment option for patients with OAB.
Phytomedicine | 2010
Ana Paula Simões-Wüst; Mário Grãos; Carlos B. Duarte; Rudolf Brenneisen; Matthias Hamburger; Mónica Mennet; M.H. Ramos; Martin Schnelle; R. Wächter; A.M. Worel; U. von Mandach
The use of preparations from Bryophyllum pinnatum in tocolysis is supported by both clinical (retrospective comparative studies) and experimental (using uterus strips) evidence. We studied here the effect of B. pinnatum juice on the response of cultured human myometrial cells to stimulation by oxytocin, a hormone known to be involved in the control of uterine contractions by increasing the intracellular free calcium concentration ([Ca2+]i). In this work, [Ca2+]i was measured online during stimulation of human myometrial cells (hTERT-C3 and M11) with oxytocin, which had been pre-incubated in the absence or in the presence of B. pinnatum juice. Since no functional voltage-gated Ca2+ channels could be detected in these myometrial cells, the effect of B. pinnatum juice was as well studied in SH-SY5Y neuroblastoma cells, which are known to have such channels and can be depolarised with KCl. B. pinnatum juice prevented the oxytocin-induced increase in [Ca2+]i in hTERT-C3 human myometrial cells in a dose-dependent manner, achieving a ca. 80% inhibition at a 2% concentration. Comparable results were obtained with M11 human primary myometrial cells. In hTERT-C3 cells, prevention of the oxytocin-induced increase in [Ca2+]i was independent of the extracellular Ca2+ concentration and of voltage-dependent Ca2+-channels. B. pinnatum juice delayed, but did not prevent the depolarization-induced increase in [Ca2+]i in SH-SY5Y cells. Taken together, the data suggest a specific and concentration-dependent effect of B. pinnatum juice on the oxytocin signalling pathway, which seems to corroborate its use in tocolysis. Such a specific mechanism would explain the rare and minor side-effects in tocolysis with B. pinnatum as well as its high therapeutic index.
Phytomedicine | 2014
C. Lambrigger-Steiner; Ana Paula Simões-Wüst; Angela Kuck; Karin Fürer; Matthias Hamburger; U. von Mandach
INTRODUCTION Poor sleep quality in pregnancy is frequent. A treatment with sedatives is problematic due to possible adverse effects for mother and embryo/foetus. In the present study, we investigated the sedative effect of Bryophyllum pinnatum, a phytotherapeutic medication used in anthroposophic medicine. In previous clinical studies on its tocolytic effect, B. pinnatum showed a good risk/benefit ratio for mother and child. A recent analysis of the prescribing pattern for B. pinnatum in a network of anthroposophic physicians revealed sleep disorders as one of the most frequent diagnoses for which these preparations are prescribed. MATERIALS AND METHODS In this prospective, multi-centre, observational study, pregnant women suffering from sleep problems were treated with B. pinnatum (350mg tablets, 50% leaf press juice, Weleda AG, Arlesheim, dosage at physicians consideration). Sleep quality, daily sleepiness and fatigue were assessed with the aid of standardised questionnaires, at the beginning of the treatment and after 2 weeks. Possible adverse drug reactions perceived by the patients during the treatment were recorded. RESULTS The number of wake-ups, as well as the subjective quality of sleep was significantly improved at the end of the treatment with B. pinnatum. The Epworth Sleeping Scale decreased, indicating a decrease of the tiredness during the day. There was, however, no evidence for prolongation of the sleep duration, reduction in the time to fall asleep, as well as change in the Fatigue Severity Scale after B. pinnatum. No serious adverse drug reactions were detected. CONCLUSION B. pinnatum is a suitable treatment of sleep problems in pregnancy. The data of this study encourage further clinical investigations on the use of B. pinnatum in sleep disorders.
Gynakologisch-geburtshilfliche Rundschau | 2004
E. Gut; Jörg Melzer; U. von Mandach; Reinhard Saller
Bisher gibt es kaum systematisch erhobene Daten über den Gebrauch von Naturheilmitteln während Schwangerschaft und Stillzeit. Ziel dieser Pilotstudie an einem nicht repräsentativen Kollektiv von 139 Frauen, die von Mitte 1997 bis zum 2. Quartal 1998 zur Entbindung in drei geburtshilfliche Einrichtungen kamen, war es, Daten zu den Fragen nach der Häufigkeit und dem Spektrum der angewandten Naturheilmittel während Schwangerschaft und Stillzeit zu erheben. Während der Schwangerschaft nahmen mindestens 96% und in der Stillperiode 84% der Frauen mindestens 1 Naturheilmittel ein, wobei jeweils Phytotherapeutika am häufigsten benutzt wurden. Im Gegensatz zum weit verbreiteten Gebrauch von Naturheilmitteln bei Schwangeren und Stillenden in dieser Studie, und ihren Fragen dazu, existieren wenige nachvollziehbare Daten zur Wirksamkeit und zu einem eventuellen Risiko. Während der Schwangerschaft und Stillzeit benutzte Naturheilmittel sollten dahingehend gesichtet und beurteilt werden.
European Journal of Endocrinology | 2004
J Bielicki; Renate Huch; U. von Mandach
Phytomedicine | 2015
Karin Fürer; Daniel Eberli; Cornelia Betschart; Rudolf Brenneisen; M De Mieri; Matthias Hamburger; M Mennet-von Eiff; Olivier Potterat; Martin Schnelle; Ana Paula Simões-Wüst; U. von Mandach
Planta Medica | 2013
Karin Fürer; Daniel Eberli; Cornelia Betschart; Rudolf Brenneisen; Matthias Hamburger; U. von Mandach
Gynakologisch-geburtshilfliche Rundschau | 2004
H.S. Scholz; E. Petru; Karl Tamussino; R. Winter; Martin Birkhäuser; C. de Geyter; Paul J. Keller; F. Luzuy; U. von Mandach; Reinhard Saller; W. Braendle; L. Kiesel; H. Kuhl; J. Neulen; H. Hepp; U. Haller; J.W. Janni; E. Klanner; B. Rack; H. Sommer; K. Friese; Daniel Fink; Mathias K. Fehr; E. Gut; Jörg Melzer; Jorge E. Tapia
European Journal of Integrative Medicine | 2010
Ana Paula Simões-Wüst; Mário Grãos; C.J. Duarte; Rudolf Brenneisen; Matthias Hamburger; Mónica Mennet; Martin Schnelle; R. Wächter; A.M. Worel; U. von Mandach